Biotech Startups

Cellectis is a biotech company focused on cell therapy and immunotherapy. The company is publicly listed on Nasdaq and Euronext Growth Paris.

1 investor

Cellemedy develops next-generation therapeutic proteins designed to replace conventional antibody treatments in healthcare.

1 investor

Cellera Farma is a Brazilian pharmaceutical company that manages a portfolio of established medical products through partnerships, licensing, distribution, promotion, and proprietary products. It focuses on therapeutic areas including central nervous system, gastroenterology, orthopedics, and pediatrics.

1 investor

Cellergy develops allogeneic mitochondrial transplantation therapy, producing GMP-grade purified mitochondria from human primary cells for intravenous, repeated administration. Its therapy targets systemic and degenerative conditions such as CNS disorders, muscle degeneration, and aging, and uses a machine-learning model to predict donor/recipient matching.

1 investor

Cellergy Pharma develops immunotherapies for patients with severe allergic disease and cancer.

1 investor

Cellestial Health is a preclinical-stage biotech developing therapies for Parkinson's disease, with a lead candidate rooted in astrocytic network biology. The company focuses on drug discovery for neurological disease.

1 investor

Cellevate develops Cellevat3d nanofiber-based microcarriers and cell culture systems for upstream bioprocessing, used in viral vector, viral vaccine, and stem cell production by gene therapy and biopharmaceutical organizations. Founded as a spinout from NanoLund and Prof. Lars Montelius's group, the company focuses on commercializing nanofiber cell culture technology.

1 investor

Cellipont Bioservices is a contract development and manufacturing organization (CDMO) that provides GMP manufacturing and development services for advanced cell therapies. It serves pharma and biotech clients developing cell therapy treatments.

1 investor

CellMax Life appears to be a diagnostics company, though the page provided only contains a biography of John Sninsky (Chief Scientific Officer) with no explicit company description, products, or business model stated.

1 investor

CellON develops plant and wood-based material technologies, including SuperFibre and Nanogel products, designed to replace synthetic materials in applications requiring oil resistance, fire prevention, or antimicrobial properties. The company serves manufacturers seeking sustainable, biodegradable alternatives free from toxic chemicals.

1 investor

Cellpurics is a South Korean biotech company focused on stem cell technologies, including large-scale gonadal stem cell cultivation and storage, Real-time PCR-based measurement of mesenchymal stem cell anti-inflammatory capacity, and high-tech companion animal diagnostics. It also provides contract research organization (CRO) services covering in vitro and in vivo drug efficacy evaluation, veterinary drug and medical device clinical trials, GLP toxicity testing, and AI-based drug discovery.

1 investor

CellsBin develops an AI-driven photonic semiconductor platform for detecting, isolating, and characterizing rare cells in biological samples for therapeutic monitoring and precision medicine applications. The company serves researchers and clinicians in drug development, cell therapy monitoring, and clinical diagnostics.

1 investor

A biotech company developing cell and gene technology solutions focused on regenerative medicine and advancing healthcare innovations.

1 investor

CellTivity Scientific provides point-of-care biopsy assessment technology to improve cancer diagnosis accuracy and speed. The company aims to reduce diagnostic delays and uncertainty while preparing samples for next-generation sequencing.

1 investor

CellTrack develops a cell-labeling technology that attaches Zirconium-89 to therapeutic cells for non-invasive PET imaging, allowing tracking of cell biodistribution in vivo for over 7 days. The company targets pharma companies and CDMOs developing cell therapies, aiming to provide biodistribution data for clinical trials.

1 investor

Celltrio manufactures robotic automation systems for the life sciences industry, with patented technology for biobanking and cell culturing automation. The company licenses IP from a Korean robotics partner and develops products with a US-based engineering team.

1 investor

Cellular Highways manufactures the Highway1 Cell Sorter, a benchtop instrument for high-throughput cell sorting applications in research. The company serves life science researchers requiring fast, gentle cell sorting with high cell viability.

1 investor

Cellumed is a South Korean biotech company focused on musculoskeletal medical devices and biological products. It also develops and supplies growth factors and production enzymes used for RNA vaccines and therapeutics.

1 investor

Cellva creates natural ingredients from Brazilian agricultural supply chains using proprietary technology to transform raw materials into food-grade solutions. The company serves food manufacturers and CPG brands seeking to improve formulation efficiency, cost reduction, and sensory performance in food applications.

1 investor

Celmatix Therapeutics developed a discovery portfolio focused on women's health, including therapeutic programs for infertility, endometriosis, and ovarian aging. The company's pipeline included an oral FSH receptor agonist, a JNK inhibitor, and AMH-targeting antibodies.

1 investor

Cenevo is a life science technology company that provides integrated lab management software combining electronic lab notebooks, LIMS, sample management, and AI-enabled automation for research organizations. The platform serves biotech firms, pharmaceutical companies, and research institutions seeking to streamline lab operations and accelerate scientific discovery.

1 investor

Centaur Pharmaceuticals is an integrated Indian pharmaceutical company operating across active pharmaceutical ingredients (APIs), finished formulations, clinical research, and contract manufacturing, with distribution reaching 120 countries. It manufactures psychotropic APIs and branded formulations such as the anti-cold brand Sinarest, and conducts clinical trials through its LifeSan research arm.

1 investor

Centrillion develops high-density DNA chips combined with AI-powered analysis to generate genomic and cellular data at scale for biological research. The platform enables researchers to ask thousands of variant questions in a single assay and decode genomes, cells, and tissues using AI models.

1 investor

Cephagenix is a biotech company working on identifying and developing new treatments for migraine.

1 investor